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Abstract: The purpose of this study was to develop a pharmaceutical formulation containing fatty
acid extract rich in free omega-3 fatty acids such as eicosapentaenoic acid and docosahexaenoic acid
for topical use. Although the health benefits of cod liver oil and other fish oils taken orally as a dietary
supplement have been acknowledged and exploited, it is clear that their use can be extended further
to cover their antibacterial properties. In vitro evaluation showed that 20% (v/v) fatty acid extract
exhibits good activity against strains of the Gram-positive bacteria Staphylococcus aureus, Enterococcus
faecalis, Streptoccoccus pyogenes and Streptoccoccus pneumonia. Therefore, free polyunsaturated fatty
acids from cod liver oil or other fish oils can be used as safe and natural antibacterial agents. In this
study, ointment compositions containing free fatty acids as active antibacterial agents were prepared
by using various natural waxes and characterized. The effects of different waxes, such as carnauba
wax, ozokerite wax, laurel wax, beeswax, rice bran wax, candelilla wax and microcrystalline wax, in
the concentration range of 1% to 5% (w/w) on the ointment texture, consistency and stability were
evaluated. The results showed significant variations in texture, sensory and rheological profiles. This
was attributed to the wax’s nature and chain composition. Microcrystalline wax gave the best results
but laurel wax, beeswax and rice bran wax exhibited excellent texturing, similar sensory profiles and
well-balanced rheological properties.
Keywords: PUFA (polyunsaturated fatty acid); DHA (docosahexaenoic acid); EPA (eicosapentaenoic
acid); FA (fatty acid); ointment
1. Introduction
The nutritional and medical benefits of fish oils that are rich in polyunsaturated fatty acids
(PUFAs) have been extensively investigated. For example, numerous studies have confirmed that
PUFAs possess anti-inflammatory properties and, thus, regular fish oil consumption is thought to
reduce the risk of cardiovascular diseases [1,2]. Fish liver oil for human consumption is commonly
extracted from Atlantic cod (Gadus morhua). The fatty acid composition of cod liver oil is shown in
Table 1. It contains saturated, monounsaturated and various PUFAs, including both eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA) [3]. Antibacterial, antiviral and antifungal effects have
also been associated with PUFAs [4–8]. It has been reported that the unsaturated fatty acids’ (FAs)
potency increases with the degree of unsaturation, while esterified FAs are less effective than free
FAs [9]. Similarly, for cod liver oil, it has been shown that the extract of free FAs from cod liver oil is
more potent than cod liver oil containing the same FAs in the form of triglycerides [10,11]. Besides
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the strong antibacterial properties, free FAs also possess antiviral properties and the FAs extract from
cod liver oil has been shown to cause a significant reduction of herpes simplex virus type 1 HSV-1
activity. 1% FAs extract caused a 50,000 fold or greater (ě4.7 log10) reduction of viral infectivity in
10 min [12]. In addition, PUFAs have been used as penetration enhancers in transdermal and buccal
drug formulations [13]. To date, the mechanisms by which FAs act as antibacterial agents have not
been resolved, and this continues to be a subject of some research effort. Although the exact mode of
the bactericidal action of fatty acids still remains unclear, the cellular membrane is thought to be the
primary target [14,15].
Table 1. Typical fatty acid composition of fatty acid extract from cod liver oil [13].
Fatty Acid Amount (%)
Name Shorthand
Saturated fatty acids
Myristic acid 14:0 3.6
Palmitic acid 16:0 10.4
Stearic acid 18:0 2.6
Monounsaturated fatty acids
Palmitoleic acid 16:1 n-7 6.5
cis-Vaccenic acid 18:1 n-7 4.4
Oleic acid 18:1 n-9 16.2
Gondoic acid 20:1 n-9 9.4
Gadoleic acid 20:1 n-11 1.6
Erucic acid 22:1 n-9 0.6
Cetoleic acid 22:1 n-11 7.8
Polyunsaturated fatty acids
Linoleic acid 18:2 n-6 1.5
Moroctic acid 18:4 n-3 2.4
Eicosapentaenoic acid (EPA) 20:5 n-3 9.3
Docosahexaenoic acid (DHA) 22:6 n-3 11.9
Ointments are semi-solid, homogenous, viscous pharmaceutical preparations usually intended
for external use such as on skin or mucosal membranes [16]. Waxes are frequently used as hydrophobic
excipients in topical drug formulations to obtain desired viscosity and consistence [17]. Waxes are a
large and complex group of lipophilic compounds that generally consist of mixtures of esters of fatty
acids with long-chain monohydric alcohols [18]. Today, a wide variety of natural and synthetic waxes
are utilized in cosmetics and pharmaceutical products. Seen from a pharmacological aspect, waxes are
recognized as a potential excipient or enhancing the aesthetic and maximizing the therapeutic benefits
of topical formulations by increasing the viscosity and prolonging the drug retention on the skin
surface [19,20]. The objective of this study is to evaluate the antibacterial properties of the fatty acid
extract from cod liver oil and design a suitable pharmaceutical formulation for topical administration
of the fatty acid extract. This article briefly describes the use of waxes as lipophilic excipients for
ointments and how selected waxes influence the ointments’ rheological and sensory properties.
2. Results
The compositions of the ointments tested are shown in Table 2. The final ointment formulation
was obtained by adding 40% (w/w) fatty acid extract to a mixture of Vaseline, coconut butter, wax
base, lavender oil and lemon oil.
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Table 2. Composition (% w/w) of ointments.
Formulation Code
Compound (% w/w)
Fatty Acid
Extract Vaseline
Coconut
Butter Wax Lavender Oil Lemon Oil
C1, O1, L1, B1, Cd1, Rb1, M1 40 43.5 14 1 1 0.5
C2, O2, L2, B2, Cd1, Rb2, M2 40 43.5 12 3 1 0.5
C3, O3, L3, B3, Cd3, Rb3, M3 40 43.5 10 5 1 0.5
Compositions of ointments tested: wax is carnauba (C1, C2, C3), ozokerite (O1, O2, O3), laurel (L1,
L2, L3), bees (B1, B2, B3), candelilla (Cd1, Cd2, Cd3), rice bran (Rb1, Rb2, Rb3) and microcrystalline
(M1, M2, M3). Each wax was tested at three levels (1%, 3% and 5% (w/w)).
2.1. In Vitro Evaluation of Antibacterial Activity of Fatty Acid Extract
The fatty acid extract from fish liver oil was subjected to antibacterial efficiency testing
using strains of representative species of both Gram-positive and Gram-negative bacteria. As
determined by the agar dilution method, the extract showed antibacterial activity against all
four tested Gram-positive strains: Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes
and Streptococcus pneumonia. However, the extract did not show antibacterial activity against the
Gram-negative bacteria Pseudomonas aeruginosa and Escherichia coli in this study (MIC > 16.384 µg/mL)
(Table 3).
Table 3. Minimum inhibitory concentration (MIC) for the fatty acid extract.
Strains
Staphylococcus
aureus
Streptococcus
pyogenes
Streptococcus
pneumonia
Enterococcus
faecalis
Pseudomonas
aeruginosa
Escherichia
coli
ATCC ATCC ATCC ATCC ATCC ATCC
29213 19615 49169 29212 27853 25922
MIC (µg/mL) 512 256 128 256 >16.384 >16.384
2.2. Evaluation of Ointments
The ointments were evaluated for their physical properties such as their spreadability,
extrudability and pH as well as their appearance. Spreadability, extrudability and pH studies were
carried out in triplicate and average values are reported.
2.2.1. Spreadability Measurements
Ointment spreadability was found to be inversely proportional to the wax concentration. As the
wax amount was increased the ointments became more viscous and, consequently, increasing the wax
concentration from 1% to 5% led to decreased spreadability. Spreadability measurements are presented
in Table 4. Formulations B1, B2, and B3 exhibited the highest spreadability while formulations C1, C2,
C3 and O1, O2 and O3 displayed the lowest spreadability. No statistically significant difference was
found between formulations L1, L2, L3 and M1, M2, M3. Formulations Cd1, Cd2, Cd3 and Rb1, Rb2,
Rb3 showed good spreadability and were not as fluid as B1, B2, B3 and not as stiff as C2, C3, O2, O3.
The spreading values of these formulations were in the following order: B1 > B2 > B3 > L1 > M1 >
L2 > Rb1 > M2 > C1 > O1 > L3 > Cd1 > Rb2 > M3 > Cd3 > Cd2 > Rb3 > O2 > C2 > C3 > O3.
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Table 4. Spreadability, extrudability and pH values of ointments.
Formulation Spreadability (mm ˘ SD) Tube Extrudability (g ˘ SD) pH
C1 21.50 ˘ 0.87 3.23 ˘ 0.19 5.44 ˘ 0.04
C2 14.66 ˘ 0.20 1.84 ˘ 0.05 5.21 ˘ 0.01
C3 13.33 ˘ 0.57 1.67 ˘ 0.10 5.06 ˘ 0.05
O1 19.66 ˘ 0.57 3.23 ˘ 0.39 4.70 ˘ 0.03
O2 15.66 ˘ 0.2 2.84 ˘ 0.62 4.62 ˘ 0.07
O3 12.66 ˘ 1.5 1.69 ˘ 0.53 4.48 ˘ 0.02
L1 25.33 ˘ 2.51 2.50 ˘ 0.12 3.83 ˘ 0.03
L2 22.66 ˘ 0.57 2.15 ˘ 0.07 4.03 ˘ 0.005
L3 19.66 ˘ 1.52 2.04 ˘ 0.09 4.06 ˘ 0.05
B1 30.50 ˘ 1.32 4.84 ˘ 0.79 4.30 ˘ 0.03
B2 30.13 ˘ 0.28 3.95 ˘ 0.49 4.05 ˘ 0.05
B3 27.33 ˘ 0.57 3.32 ˘ 0.07 3.96 ˘ 0.01
Cd1 19.33 ˘ 1.15 3.30 ˘ 0.26 4.28 ˘ 0.04
Cd2 17.33 ˘ 0.57 3.20 ˘ 0.10 3.84 ˘ 0.02
Cd 17.66 ˘ 0.57 2.92 ˘ 0.36 3.83 ˘ 0.02
Rb1 22.50 ˘ 0.50 2.97 ˘ 0.67 4.85 ˘ 0.02
Rb2 18.66 ˘ 0.57 1.67 ˘ 0.34 4.54 ˘ 0.03
Rb3 17.33 ˘ 1.52 1.24 ˘ 0.16 4.32 ˘ 0.02
M1 24.66 ˘ 6.65 3.30 ˘ 0.26 4.24 ˘ 0.02
M2 21.66 ˘ 0.57 3.33 ˘ 0.14 4.21 ˘ 0.01
M3 18.66 ˘ 2.88 2.90 ˘ 0.13 4.09 ˘ 0.02
2.2.2. Extrudability Measurements
Increasing the wax concentration resulted in decreased extrudability. In nearly all cases the
increased wax concentration from 1% to 5% led to a considerable decrease in tube extrudability except
in formulations Cd1, Cd2, Cd3, and M1, M2, M3, and L2, L3 wherein the decrease in extrudability
with the increasing wax concentration was less pronounced. Increasing the concentration of rice bran
wax and microcrystalline wax had a less dramatic but still pronounced effect on extrudability. As
can be seen in Table 4, ointments formulated with carnauba wax had the lowest extrudability, while
ointments formulated with beeswax were less viscous and had the highest extrudability.
The extrudability values of these formulations were in the following order: Rb3 > C3 = Rb2 > O3
> C2 > L3 > L2 > L1 > O2 > M3 > Cd3 > Rb1 > O1 = C1 > M1 = Cd1 > B3 > Rb3 > M2 > B2 > B1.
2.2.3. Determination of pH
As shown in Table 4, the pH of the ointments ranged from 3.83 to 5.44, and, in general, increasing
the wax concentration from 1% to 5% resulted in a slight pH decrease with the exception of L1, L2,
and L3 wherein the pH slightly increased. In fact, pH increased when the laurel wax concentration
was increased from 1% to 3%, but almost no changes were found when the laurel wax concentration
was increased from 3% to 5%. The pHs of L1 (3.83 ˘ 0.03), B3 (3.96 ˘ 0.01), Cd2 (3.84 ˘ 0.02), Cd3
(3.83 ˘ 0.02) were slightly below 4. Of all the ointments tested, the lowest pH was observed in L1
(contains 1% laurel wax), and the highest in C1 (contains 1% carnauba wax).
2.2.4. Determination of Lipid Oxidation
The results of the peroxide value (PV) assay (Figure 1) represent how stable the PUFAs were
during storage for six months at ambient temperature (i.e., 22–23 ˝C) and for three months under
accelerated conditions (i.e., 40 ˝C). The content of the primary lipid oxidation products measured as the
PV of the extract was in the range 1.073–1.804 mmol/kg O2 at the end of three months of accelerated
testing and 0.824–1.298 mmol/kg O2 at the end of six months of storage at room temperature. In both
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cases no statistically significant differences in the PV values were observed when the wax content
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Figure 1. Lipid oxidation measured as peroxide value:  (a)  real‐time  tested period;  (b) accelerated 
tested period. 
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and its concentration, only minor changes in the brown color were observed. All formulations had a 
strong distinctive smell of fish odor. The overall best results were obtained when beeswax, rice bran 
wax,  laurel  wax  or  microcrystalline  wax  were  used  in  the  ointment  base.  Overall  cosmetic 
acceptability  was  rated  satisfactory  for  C1,  C2,  and  Cd1  and  Cd2.  Specifically,  formulations 
containing  beeswax  as well  as  laurel wax  had  an  advantage  of  providing  an  additional  glossy 
appearance without having  a negative  impact on  the homogeneity and greasiness. Compared  to 
other  unsatisfactory  formulations  that  had  a  rough,  gritty  texture  such  as  ointments  containing 
carnauba wax or ozokerite wax, ointments  that  contain  candelilla wax differ by possessing  large 
visible particles distributed throughout a glossy, homogenous ointment base. 
3. Discussion 
3.1. Antibacterial Activity of the Fatty Acid Extract 
In the present study, the antibacterial effect of the fatty acid extract obtained by the hydrolysis 
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their MICs were similar, 128–512 μg/mL. The fatty acid extract did not show antibacterial activity 
against the Gram‐negative strains in the highest concentration measured. These results agree with 
previous studies where PUFAs were shown to be more potent against Gram‐positive bacteria than 
Gram‐negative bacteria [6,9,21]. A possible explanation for the difference in susceptibility lies in the 
difference  in  the  cell wall  structure  of Gram‐positive  and Gram‐negative  bacteria  [14,22].  Some 
accumulation of the fatty acid extract was observed on the agar surface but it gradually decreased 
upon progressive dilution  to 128 μg/mL. The agar dilution method  is probably not applicable  for 
antibacterial measurements of free FAs at high concentrations due to the accumulation of the fatty 
acid extract on the agar surface. 
3.2. Ointment Design and Evaluation 
During pharmaceutical  formulation,  selection  of  appropriate  excipients  and  their  amount  is 
critical and various factors have to be considered such as the formulation appearance, odor, color 
and firmness, all of which can influence the patient acceptability. Other important factors include the 
chemical stability of the active pharmaceutical  ingredient (i.e., the drug), and the overall chemical 
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Figure 1. Lipid oxidation measured as peroxide value: (a) real-time tested period; (b) accelerated
tested period.
2.2.5. Sensory Evaluation
The physical appearance of the ointments was light brown, the color they got from the extract
present in high quantity (40% w/w) in all the ointments tested. Regardless of the type of wax used and
its concentration, only minor changes in the brown color were observed. All formulations had a strong
distinctive smell of fish odor. The overall best results were obtained when beeswax, rice bran wax,
laurel wax or microcrystalline wax were used in the ointment base. Overall cosmetic acceptability
was rated satisfactory for C1, C2, and Cd1 and Cd2. Specifically, formulations containing beeswax as
well as laurel wax had an advantage of providing an additional glossy appearance without having a
negative impact on the homogeneity and greasiness. Compared to other unsatisfactory formulations
that had a rough, gritty texture such as ointments containing carnauba wax or ozokerite wax, ointments
that contain candelilla wax differ by possessing large visible particles distributed throughout a glossy,
homogenous ointment base.
3. Discussion
3.1. Antibacterial Activity of the Fatty Acid Extract
In the present study, the antibacterial effect of the fatty acid extract obtained by the hydrolysis
of cod liver oil as investigated and oint ents containing the extract ere prepared. The fatty acid
extract showed antibacterial activity against all the strains of the Gra -positive bacteria tested and
their ICs were si ilar, 128–512 µg/ L. The fatty acid extract did not show antibacterial activity
against the Gra -negative strains in the highest concentration easured. These results agree with
previous studies where PUFAs were shown to be ore potent against Gra -positive bacteria than
Gra -negative bacteria [6,9,21]. A possible explanation for the difference in susceptibility lies in
the difference in the cell wall structure of Gram-positive and Gra -negative bacteria [14,22]. So e
accu ulation of the fatty acid extract was observed on the agar surface but it gradually decreased
upon progressive dilution to 128 µg/ L. The agar dilution ethod is probably not applicable for
antibacterial measurements of free FAs at high concentrations due to the accumulation of the fatty acid
extract on the agar surface.
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3.2. Ointment Design and Evaluation
During pharmaceutical formulation, selection of appropriate excipients and their amount is critical
and various factors have to be considered such as the formulation appearance, odor, color and firmness,
all of which can influence the patient acceptability. Other important factors include the chemical
stability of the active pharmaceutical ingredient (i.e., the drug), and the overall chemical and physical
stability of the formulation. Sometimes, it is necessary to use several different excipients to obtain the
vehicle of desired physicochemical properties. The main reason is that it is frequently impossible for
a single excipient to produce an ideal vehicle (here an ointment base), but a combination of several
excipients frequently will give vehicles with enhanced aesthetics as well as increase drug potency and
bioavailability [23,24]. Vaseline is the most common lipophilic excipient in dermal formulations and
its usage is sometimes associated with its occlusive properties that can enhance penetration of the
active ingredient into skin and improve the therapeutic efficacy of the product [17]. Our experience is,
however, that the use of Vaseline alone as an excipient where prolonged drug retention is desirable is
not likely to result in acceptable formulation. Waxes were chosen as viscosity-building excipients to
improve the ointments’ performance and give them optimal rheological profiles. The combination
of Vaseline and waxes produced pharmaceutically acceptable ointments that were less greasy than
pure Vaseline and that were retained on the skin for a sufficiently long time to allow for extended
drug delivery. The spreadability and extrudability profiles were found to be satisfactory for a topical
dosage form. Spreadability and tube extrudability do, in principle, correlate with the rheological
properties and present a simple and accurate approach to understanding the relationship between
viscosity and the force needed to squeeze the ointment out of a tube [25–27]. Both measurements
showed the ointment’s tendency to become stiffer upon incorporation of wax. The rheological effect
can be explained by the nature of the fatty acid moieties of the waxes. The greater the saturated fatty
acid fraction of the wax structure, the more viscous the ointments will be, and, conversely, the viscosity
of the ointments will decrease with increasing content of unsaturated fatty acids [28]. Spreadability
and extrudability values were influenced by both the amount and type of wax used.
In most cases the pH of the ointments was within acceptable pH range for dermal preparations
(the pH of the skin surface is between 4.2 and 5.6). The presence of wax led to an increase in pH, except
in the case of laurel wax. No significant change in pH was observed when the wax concentration of the
ointments was increased. Acidic pH values were expected due to the high concentration (40% w/w) of
free FAs. FAs are weak acids with a pKa value of about 4.8 that increases slightly with the increasing
chain length [29]. In general, it is recommended that the pKa value for a drug to be used is between 4
and 8 to avoid itching or skin irritation [30]. Irritation or redness at the site of application is frequently
observed if the active ingredients have a pH different from that of the skin, especially in people with
tender skin [31,32].
Besides the therapeutic efficacy, sensory acceptability also decides the marketing success of the
topical formulation. Formulating a product that possess both optimal efficacy and expected sensory
qualities can be extremely challenging [33]. The analysis of sensory profile is not a straightforward
process, but frequently it is related to the physiological properties of the product ascribed by the
formulation’s homogeneity, consistency or firmness [34]. Factors that can influence the homogeneity
of the ointment include the solidification profile of the composition during its preparation such as the
cooling rate, and variations in preparing techniques. Except for the type of wax used, all the ointment
components were identical, as was the method of preparation.
3.3. Stability Studies
Fish oil is particularly susceptible to rancidity due to its high content of omega-3 PUFAs which
are highly prone to oxidation. Monitoring the PV of the ointments allowed us to determine the fatty
acid rancidification. As can be seen in Figure 1, no correlation between PV and presence of wax was
found, and the increased wax concentration did not alter the PV of any of the ointments tested. In all
cases, except in formulation O1, there was a rapid increase in the peroxide value during the first month
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of storage at 40 ˝C. A possible explanation could be the presence of oxygen in the headspace of the
sealed tubes. After that, the PV increased only slightly with time under both ambient and accelerated
conditions (i.e., at 40 ˝C). It was evident that oxidation of the PUFAs occurred under both ambient
and accelerated storage conditions, but it was independent of ointment composition. However, there
was very little lipid peroxidation, as the PVs in all of the ointments were below the suggested limit for
acceptability and quality for fish oils for human consumption. All formulations tested met the quality
standards of the European Pharmacopeia [35].
Stability studies of ointments were further supported by the evaluation of sensory parameters
(data not shown). All ointments containing microcrystalline wax, rice bran wax, laurel wax or beeswax
were stable during the six months of storage at room temperature and displayed no change in texture,
color or smell. A deviation from initial sensory parameters was observed in the case of C1, C3, O1, O2,
Cd1 and Cd2 after six months of storage under ambient conditions as well as at 40 ˝C. A slight change
in color in the formulations at 40 ˝C and “bleeding“ after 90 days was observed. The phenomenon of
bleeding was attributed to the storage at high temperature which, in fact, is a well-known change in
consistency that typically appears on the top of a filled tube and is frequently referred to as the main
stability problem of ointments [36]. According to the results obtained from a short-duration stability
study, C1, C2, O1, O2, Cd1, Cd2 and all formulations containing rice bran, laurel or beeswax were
slightly different in homogeneity than the original samples. However, besides the textural and sensory
changes, phase separation was not observed.
4. Materials and Methods
4.1. Antibacterial Assay
The strains selected to use for the antibacterial assay were Staphylococcus aureus (ATCC2913),
Enterococcus faecalis (ATCC29212), Streptococcus pyogenes (ATCC19615) and Streptococcus pneumoniae
(ATCC49169) representing common Gram-positive species, and Pseudomonas aeruginosa (ATCC27853),
and Escherichia coli (ATCC 25922) representing Gram-negative species. MIC determinations were
performed using agar dilution according to the CLSI standard for methods for dilution antimicrobial
tests for bacteria that grow aerobically [37]. Double dilutions of FAs extract of cod liver oil were
prepared. One mL of each included 381 µL of FAs, 200 µL ethanol and 419 µL of sterile distilled
water that was added to 19 mL of melted Mueller-Hinton agar (Oxoid, Hampshire, UK), mixed and
poured in sterile Petri dishes to obtain the final concentrations of 1–16.384 µg/mL. For the MIC testings
of streptococci the agar was supplemented with 5% sheep blood. Bacterial suspensions were made
to include approximately 107 CFU/mL, to give the final number of 104 CFU in the 1 µL that was
placed on the agars that were incubated at 37 ˝C for 18–24 h. The MIC determinations were done two
times for each strain and dilution. Various concentrations of ethanol (20%, 40%, 60%, 80%, and 100%)
(Sigma Aldrich, Steinheim, Germany) without FAs extract was used to evaluate the effect of the ethanol.
Mueller Hinton agar without alcohol and FAs extract was used for growth control.
4.2. Ointment Preparation
The fatty acid extract was supplied by Lýsi Ltd. (Reykjavik, Iceland).The method to determine
the content and composition of FAs present in cod liver oil and its extract has been previously
described [13]. Vaseline was purchased from Duchefa Farma (Haarlem, The Netherlands), carnauba
wax, ozokerite wax, laurel wax, candelilla wax, rice bran wax were purchased from Strahl&Pitch (West
Babylon, NY, USA), and beeswax and microcrystalline wax were purchased from Making cosmetics
(Snoqualmie, WA, USA), coconut butter was purchased from Fagron (Newcastle upon Tyne, UK),
lavender oil and lemon oil were purchased from Now Foods (Bloomingdale, IL, USA).
Twenty-one formulations were prepared by fusion method, in which the FAs extract (40% w/w)
was combined with a melted wax base and evaluated for physicochemical parameters [38]. All the
compositions are summarized in Table 2. Free FAs extract was heated gently on a water bath at 50 ˝C
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until the entire content has melted. Simultaneously, wax was completely melted under stirring. When
wax base had melted, both Vaseline and coconut oil were added. Free FAs extract was added slowly to
the mixture under gentle stirring. Then, lavender oil and lemon oil were added and mixed together
with Vaseline, coconut oil and waxes. The ointments were filled in airtight aluminum tubes in order to
prevent access of light and oxygen.
4.3. Evaluation of Ointments
4.3.1. Spreadability
A simple spreadability test was performed: 1.0 g of the ointment was placed in a 10-mm-diameter
circle on a glass plate. After being sandwiched with another glass plate, the sample was pressed with
fixed 500 g weight [39]. Spreadability was determined as a difference in diameter values before and
after 30 s on a millimeter scale placed under the lower glass plate.
4.3.2. Extrudability
Tube extrudability was determined by measuring the amount of ointment extruded from the
tube when a pressure was applied on the tube. The larger amount extruded the better extrudability.
Extrudability was determined in terms of weight in grams required to extrude 0.5 cm of ribbon of
ointment in 5 s [40].
4.3.3. pH Determination
The pH of ointments were determined by an extraction method where 2.5 g of ointment was
suspended in 50 mL distilled water in a 100 mL beaker, heated in a water bath at about 70 ˝C for
10 min, and then cooled to room temperature. The suspension was vigorously stirred for 10 min on
magnetic stirrer to prompt extraction before phase separation resulting in supernatant extract [41]. The
pH was measured using a PH-200 Waterproof pH Meter.
4.3.4. Sensory Evaluation
Sensory parameters of ointments were evaluated at different storage conditions, that is 40 ˘ 2 ˝C,
75% RH ˘ 5% RH for three months and under ambient condition for six months. The colors, odors and
textures of the ointments were evaluated and compared. A standardized quantity of 1 g of ointment
was applied over the dorsal surface of the left hand and sensory properties descriptively graded using
terms as follows:
(1) Excellent: smooth and homogeneous texture, light brown color, distinctive fishy odor.
(2) Satisfactory: smooth texture, non-consistency, light brown color, distinctive fishy odor.
(3) Unsatisfactory: rough texture, visible solid particles, non- consistency, dark brown color, rancid
fishy odor.
4.3.5. Determination of Peroxide Value
A modified method of Wheeler described in ISO 3960:2007 was used where lipid peroxide is
reacted with potassium iodide (KI) to liberate iodine that is then titrated with a standard solution of
sodium thiosulfate (Na2S2O3). The amount of liberated iodide represents the peroxide content. PV is
defined as the amount of peroxides oxygen per 1 kg fat (mmol O2/kg). Aluminum tubes were kept at
room temperature with no access of oxygen, during six months period. All the developed formulations
were also subjected to accelerated stability at testing at 40 ˘ 2 ˝C, 75% RH ˘ 5% RH for three months.
For three months accelerated study, PV was assessed at one, two and three months.
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5. Conclusions
In the current trend for the development of natural and safe antibacterial compounds with
minimal side effects, although not potent, fatty acid extract from fish liver oil has proved to be an
effective antibacterial agent against Gram-positive bacteria. As such, fish oil holds a great potential as
an active pharmaceutical ingredient for novel effective pharmaceutical formulations, especially for the
prevention and treatment of skin diseases. The ointments were shown to have a great potential as an
effective and safe way to administer PUFAs for topical antimicrobial therapy. In addition, it may be
concluded that waxes could be used as suitable excipients for ointments creating compositions with
appreciated rheological and sensory profiles that perform safe and overall effective dermal therapy.
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